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1. Introduction 
Diarylmethylamines are key building blocks and potential 
intermediates for some biologically significant pharmaceuticals.
1
 
Our studies directed towards the catalytic asymmetric addition 
reaction of an N-PMP (4-methoxyphenyl)-imine were disclosed 
first in 1990 by using 5 mol% of chiral aminoether as a catalytic 










-controlled asymmetric Mannich-type addition of 
lithium ester enolate to imines. Chiral amidophosphane-
copper(II) catalyst was the second generation for asymmetric 
alkylation of N-sulfonylimine with diorganozinc reagents.
67
 The 
continuing studies of catalytic carbon-carbon bond forming 
reaction resulted in the amidophosphane-rhodium(I) complex-
catalyzed asymmetric arylation of N-Ts (toluenesulfonyl)-
arylimine with arylboronic acids as an aryl group source in 
2004,
8
 in which ortho-trimethylsilyl substituent of arylimine was 
the key for high enantioselectivity.
9
 Then, the more general 
asymmetric arylation of a N-Dpp (diphenylphosphonyl)-
arylimine 1 was developed by relying on chiral amidophosphane 
2a, tuned sterically by introducing 2-methyl substituent on 
diphenyl-phosphane group as one of the keys which was 
anticipated by the stereochemical analysis of an imine-Rh(I)-
amidophosphane complex (Scheme 1).
10
 Produced N-Dpp-amide 
was easily deprotected to the corresponding free amine by mild 
acidic hydrolysis, being contrasting to the N-Ts protecting group 
which requires rather harsh conditions to remove off.
9
 On the 
contrary, the major problem in the arylation of N-Dpp (diphenyl-
phosphonyl)-arylimine was the competitive imine hydrolysis that 





. One of the purposes of the present study is the 
screening of phosphorus N-activating/protecting groups that 
prevent competitive imine hydrolysis. 
Scheme 1. Sterically tuned-up amidomonophosphane 2a-


















up to 99% ee1
2a
 
In our hypothetical model the C=N double bond of N-Dpp-
imine 1 is expected to coordinate to rhodium(I) on the re-face as 
shown in A to give the product with the observed S-configuration 
(Figure 1).
10a
 Coordination on the si-face (B) is unfavorable due 
to steric repulsion between the axial phenyl of the phosphorus 
(2b) and the phenyl group of Dpp. This analysis indicated that 
the bulkiness of the phenyl group on the phosphorus atom of a 
ligand favors A over B, and therefore increased bulkiness around 
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this ligand part is expected to improve the enantioselectivity of 
the reaction.  
Figure 1. Imine-Rh(I)-amidophosphane 2b complexes A and 
B. 
 
In order to experimentally confirm this hypothetical model the 
steric modification of phosphane ligand as shown in 2a was 
found to be one certain approach, and examination of the steric 
influence of imine N-phosphorous part should be another 
possibility that is also another purpose of the present study. We 
describe the steric influence of N-phosphous-arylimines on 
reactivity, competitive hydrolysis and enantioselectivity. 
2. Influences of aryl substituents on reactivity, competitive 
hydrolysis and enantioselectivity 
At first the influence of aryl substituent of the N-Dpp-
arylimines 1 was examined on the reactivity and enantio-
selectivity under the established conditions
9
 for N-Ts-imines by 
using 6.6 mol% of our prototype diphenylphosphino-ligand 2b, 6 
mol% of Rh(I) and 1.67 equiv of 4-phenylphenylboroxine as an 
aryl source in n-propanol at 60 °C for 2-5 h (Table 1). 4-Phenyl-
phenylation of benzaldehyde-imine 1a and bulkier 2-
trimethylsilylbenzaldehyde-imine 1b gave the corresponding 
addition product 3a with 70% ee in good 95% yield and 3b with 
higher 81% ee in 74% yield, respectively, as has been 
described
10a
 (entries 1 and 2). The enantioselectivity was 
determined by chiral stationary phase HPLC (See Experimental). 
1-Naphthaldimine 1c afforded 3c with 78% ee in 93% yield 
(entry 3). 4-Methylbenzaldehyde-imine 1d was converted to the 
corresponding product 3d with 69% ee in 91% yield (entry 4). 
Such small reactivity and moderate enantioselectivity 
dependencies on the bulkiness of aryl substituent indicated the 
usefulness of the model A and B where steric interaction may be 
critical at the N-protecting/activating site. Additional support to 
this hypothetical model is the fact that benzaldehyde-imine 
bearing a smaller N-Ts group was converted to the corresponding 
amide with somewhat poorer 66% ee in 83% yield,
9
 indicating 
that N-Dpp should be a little bit bulkier than N-Ts group. 
The reaction of 1a was further examined at lower 40 °C for 
prolonged 9 h to give 3a with 59% ee in 36% yield. The reaction 
in a different solvent, dioxane, at 100 °C for 2 h gave 3a with 
56% ee in 65% yield, indicating n-propanol at 60°C is the 
suitable conditions.  
 
Table 1. Rh(I)-2b-catalyzed asymmetric 4-phenylphenylation 
of imines 1  























entry 1 Ar time/h 3 yield/% ee/% 
1a 1a Ph 2 3a 95 70 
2a 1b 2-TMSC6H4    3.5 3b 74 81 
3 1c 1-Naph 5 3c 93 78 
4 1d 4-MeC6H4    3.5 3d 91 69 
a
 The data was referred from reference 10a.  
3. Preparation of N-phosphorus imines 
Other benzaldehyde-imines 6 bearing ethoxy, isopropoxy, 





 were prepared by the condensation of benzaldehyde 











 (Scheme 2). 
Scheme 2. Preparation of imine 6a-e bearing N-phosphorus 
activating/protecting groups. 










































e: 2,4,6-Mes  
4. Asymmetric 4-phenylphenylation of N-phosphorus imines 
Diethoxyphosphorimide 6a and isopropoxy derivative 6b 
were converted to the corresponding products 8a with 61% ee in 
74% yield and 8b with 53% ee in 76% yield, suggesting that 
alkoxy substituents on the phosphorus is not bulky enough than a 
phenyl group in 1a (Table 2, entries 1-3). It is important to note 
the formation of benzaldehyde in each 15% yields by competitive 
hydrolysis of imines 6a and 6b. Dicyclohexyl-phosphorimide 6c 
was better than 1a with regards to enantioselectivity, 78% ee vs 
70% ee, however, the reactivity is rather poorer than that of 1a to 
give 8c in only 10% yield and recover 6c in 81% yield without 
hydrolysis after 22 h heating at 100 °C (entry 4). Although 3,5-
xylyl phosphorimide 6d was converted to 8d in 42% yield at 
60 °C for 20 h, the enantioselectivity was 67% ee and 6d was 
recovered in 40% yield without substantial detection of 
benzaldehyde (entry 5). Imine 6e bearing the bulkiest 2,4,6-
mesitylphosphorus group was converted to 8e with expectedly 
high 88% ee. However, the yield was unsatisfactorily low of only 
3% after 8 h at 100 °C and starting imine 6e was recovered in 





Table 2. 4-Phenylphenylation of benzaldehyde-imines 6 with 







6 mol % 
Rh(acac)(C2H4)2
n-PrOH


















entry 6 R temp/°C time/h 8 yield/% ee/% 
1 6a OEt 60 4 8a 74(15
a) 61 
2 6b O
iPr 60 6 8b 76(15
a) 53 
3b 1a Ph 60 2 3a 95 70 
4 6c cHex 100 22 8c 10(81
c) 78 
5 6d 3,5-Xyl 60 20 8d 42(40
c) 67 
6 6e 2,4,6-Mes 100 8 8e 3(89
c) 88 
a Recovery % of benzaldehyde. 
b
 The data is duplicated from 
entry 1, Table 1 for easy comparison. c Recovery % of starting 
imine 6 without hydrolysis. 
5. Conclusion 
Possibility in the control of reactivity, enantioselectivity and 
competitive hydrolysis of N-phosphorus arylimine was pursued 
by examining the steric influencies of N-phosphorus groups on 
arylation. Although the bulky cyclohexyl and 2,4,6-mesityl N-
phosphous groups retarded hydrolysis, but arylation was also 
blocked. As has been expected from imine-Rh(I)-amido-
phosphane complex model, the bulkiest mesityl derivative gave 
the highest enantioselectivity of 88% although the yield was 
poorest. These clearly indicated the reality and utility of imine-
Rh(I)-amidophosphane complex model as the fundamental of our 
further approach. 
6. Experimental 
6.1. General All NMR was recorded at 500 MHz (
1
H), 125 MHz 
(
13
C), and 202 MHz (
31
P) in CDCl3. Chemical shift was 




  Colorless oil. 1H NMR: 0.33 (9H, s), 7.40-7.55 
(8H, m), 7.64 (1H, d, J = 6.1 Hz), 7.92 (4H, dd, J = 7.9, 11.7 Hz), 
8.33 (1H, d, J = 7.6 Hz), 9.59 (1H, d, J = 32.4 Hz). 13C NMR: 0.7 
(CH3), 128.46 (CH), 128.51 (d, J = 12.4 Hz, CH), 129.4 (CH), 
131.7 (d, J = 8.7 Hz, CH), 131.8 (d, J = 2.1 Hz, CH), 132.2 (CH), 
132.8 (d, J = 126 Hz, C), 135.0 (CH), 140.9 (C), 144.8 (C), 174.7 





). Anal. Calcd for C22H24NOPSi: C, 70.00; H, 6.41; 
N, 3.71. Found: C, 69.72; H, 6.65; N, 3.54.  
6.3. Diisopropyl benzylidenephosphoramidate (6b).
12 
Color-
less oil. 1H NMR: 1.35 (6H, d, J = 6.1 Hz), 1.39 (6H, d, J = 6.1 
Hz), 4.70-4.85 (2H, m), 7.45-7.55 (2H, m), 7.58 (1H, m), 7.90-
8.00 (2H, m), 9.08 (1H, d, J = 32.4 Hz). 13C NMR: 23.7 (CH3), 
23.9 (CH3), 72.0 (d, J = 6.2 Hz, CH3), 128.9 (CH), 130.4 (CH), 
133.8 (CH), 135.5 (d, J = 29.9 Hz, C), 175.1 (d, J = 5.2 Hz, CH). 
IR (KBr): 1631, 995 cm
–1
. EIMS m/z: 269 (M
+
). HRMS-EI m/z: 
Calcd for C13H20NO3P, 269.1181; Found, 269.1178. 
6.4. N-Benzylidene-P,P-dicyclohexylphosphinic amide (6c).
12 
 
Colorless solid of mp 127-128 °C. 1H NMR: 1.15-1.55 (10H, m), 
1.60-1.71 (2H, m), 1.72-1.88 (6H, m), 1.90-2.10 (4H, m), 7.45-
7.55 (2H, m), 7.56 (1H, m), 7.91 (2H, d, J = 7.6 Hz), 9.06 (1H, d, 
J = 29.3 Hz). 13C NMR: 24.8 (d, J = 3.1 Hz, CH2), 25.3 (d, J = 4.1 
Hz, CH2), 25.9 (CH2), 26.2 (CH2), 26.3 (CH2), 26.4 (CH2), 34.4 
(CH), 35.0 (CH), 128.9 (CH), 129.8 (CH), 133.1 (CH), 136.0 (d, 
J = 22.6 Hz, C), 174.2 (d, J = 9.2 Hz, CH). 31P NMR: 47.3. IR 
(KBr): 1627, 1180 cm
–1
. EIMS m/z: 317 (M
+
). HRMS-EI m/z: 
Calcd for C19H28NOP, 317.1909; Found, 317.1914. 
6.5. N-Benzylidene-P,P-bis(3,5-xylyl)phosphinic amide (6d).
12 
Colorless solid of mp 75-76 °C. 1H NMR: 2.33 (12H, s), 7.12 (2H, 
m), 7.45-7.65 (7H, m), 7.02 (2H, d, J = 7.3 Hz), 9.30 (1H, d, J = 
31.8 Hz). 13C NMR: 21.2 (CH3), 129.1 (d, J = 25.7 Hz, CH), 
129.2 (CH), 130.2 (CH), 132.7 (d, J = 126 Hz, C), 133.5 (CH), 
133.6 (d, J = 3.1 Hz, CH), 136.0 (d, J = 24.7 Hz, C), 138.1 (C), 
138.2 (C), 173.3 (d, J = 8.2 Hz, CH). IR (KBr): 1126, 694 cm
–1
. 
EIMS m/z: 361 (M
+
). HRMS-EI m/z: Calcd for C23H24NOP, 
361.1596; Found, 361.1601. 
6.6. N-Benzylidene-P,P-bis(2,4,6-mesityl)phosphinic amide 
(6e).
12 
Colorless solid of mp 149-150 °C. 1H NMR: 2.25 (6H, s), 
2.42 (12H, s), 6.82 (2H, s), 6.83 (2H, s), 7.48 (2H, m), 7.54 (1H, 
m), 7.93 (2H, d, J = 7.9 Hz), 9.30 (1H, d, J = 33.0 Hz). 13C NMR: 
20.9 (CH3), 23.0 (d, J = 3.1 Hz, CH3), 128.9 (CH), 129.2 (d, J = 
121 Hz, C), 130.2 (CH), 130.8 (d, J = 13.4 Hz, CH), 133.1 (CH), 
136.6 (d, J = 24.7 Hz, C), 140.9 (d, J = 3.1 Hz, C), 142.0 (d, J = 
10.3 Hz, C), 171.4 (d, J = 7.2 Hz, CH). IR (KBr): 1454, 1377, 
825 cm
–1
. EIMS m/z: 389 (M
+
). Anal. Calcd for C25H28NOP: C, 
77.10; H, 7.25; N, 3.60. Found: C, 77.37; H, 7.27; N, 3.54. 
6.7. General procedure for the catalytic asymmetric 4-phenyl-
phenylation of an imine with boroxine: Under argon atmosphere, a 
reaction flask was charged with Rh(acac)(C2H4)2 (15.5 mg, 0.06 
mmol), 2b (31.0 mg, 0.066 mmol), imine 1 (6) (1 mmol), and (4-
PhC6H4BO)3 (902 mg, 1.67 mmol). To the flask was added n-PrOH 
(2.5 mL). The reaction mixture was put in a preheated oil bath (60 °C 
or 100 °C), and then stirred for 2 to 22 h at the same temperature. 
After dilution with AcOEt, the mixture was washed with brine, dried 
over Na2SO4, and then concentrated. The resulting residue was 
purified through silica gel column chromatography to give 3 (8).  
6.8.  (–)-(S)-N-[Biphenyl-4-yl(phenyl)methyl]-P,P-diphenyl-
phosphinic amide (3a). Chromatography (hexane/Acetone = 
5/1) gave 3a (438 mg, 95%) as colorless solid of mp 190-191 °C. 
[α]25D –27.0 (c 0.56). 70% ee (HPLC, Daicel Chiralpak AD, 
hexane/i-PrOH = 4/1, 1.0 mL/min, 254 nm, major 14.2 min and 
minor 17.4 min). 1H NMR: 3.66 (1H, dd, J = 6.4, 9.8 Hz), 5.50 
(1H, dd, J = 9.8, 11.6 Hz), 7.24-7.35 (8H, m), 7.36-7.40 (4H, m), 
7.41-7.49 (4H, m), 7.52 (2H, d, J = 8.2 Hz), 7.57 (2H, d, J = 8.2 
Hz), 7.84-7.88 (4H, m). 13C NMR: 58.3 (CH), 127.1 (CH), 127.2 
(CH), 127.3 (CH), 127.6 (CH), 128.1 (CH), 128.4 (d, J = 13.4 Hz, 
CH), 128.6 (CH), 128.8 (CH), 131.9 (CH), 132.3 (d, J = 8.8 Hz, 
CH), 132.31 (d, J = 129 Hz, C), 132.39 (d, J = 8.8 Hz, CH), 
132.41 (d, J = 129 Hz, C), 140.1 (C), 140.8 (C), 142.4 (d, J = 4.1 
Hz, C), 143.3 (d, J = 4.1 Hz, C). 31P NMR: 22.3. IR (KBr): 1184, 
725, 694 cm
–1
. EIMS m/z: 459 (M
+
). Anal. Calcd for 
C31H26NOP: C, 81.03; H, 5.70; N, 3.05. Found: C, 80.75; H, 
5.87; N, 3.08. 
6.9. (–)-N-[Biphenyl-4-yl-(2-trimethylsilylphenyl)methyl]di-
phenylphosphinic amide (3b). Chromatography 
(hexane/Acetone = 5/1) gave 3b (395 mg, 74%) as colorless solid 
of mp 211-212 °C. [α]25D –27.6 (c 1.00). 81% ee (HPLC, Daicel 
Chiralpak OD-H, hexane/i-PrOH = 10/1, 1.0 mL/min, 254 nm, 
major 7.8 min and minor 14.9 min). 1H NMR: –0.17 (9H, s), 3.74 
(1H, dd, J = 6.1, 9.8 Hz), 5.83 (1H, dd, J = 9.8, 11.0 Hz), 7.25 
(1H, m), 7.32-7.36 (5H, m), 7.39-7.44 (5H, m), 7.47-7.49 (4H, 
m), 7.53-7.57 (3H, m), 7.73-7.77 (3H, m), 7.91-7.95 (2H, m). 13C 
NMR: 0.04 (CH3), 56.7 (CH), 126.5 (CH), 127.0 (CH), 127.1 
(CH), 127.3 (CH), 128.3 (d, J = 12.4 Hz, CH), 128.6 (d, J = 12.4 
Hz, CH), 128.8 (CH), 129.3 (CH), 129.4 (CH), 131.7 (CH), 
131.80 (CH), 131.83 (d, J = 129 Hz, C), 131.9 (CH), 132.5 (d, J = 
129 Hz, C), 133.1 (d, J = 10.3 Hz, CH), 134.8 (CH), 138.4 (C), 
140.0 (C), 140.7 (C), 143.6 (d, J= 3.1 Hz, C), 143.6 (d, J = 4.1 Hz, 
C). 31P NMR: 20.2. IR (KBr): 1126, 845 cm
–1






). HRMS-EI m/z: Calcd for C34H34NOPSi: 531.2147. 
Found: 531.2153.  
6.10. (–)-N-[Biphenyl-4-yl(naphthylmethyl)diphenylphos-
phinic amide (3c). Chromatography (hexane/Acetone = 5/1) 
gave 3c (473 mg, 93%) as colorless solid of mp 228-229 °C. 
[α]25D –12.5 (c 1.04). 78% ee (HPLC, Daicel Chiralpak OD-H, 
hexane/i-PrOH = 4/1, 1.0 mL/min, 254 nm, major 6.8 min and 
minor 10.4 min). 1H NMR: 3.76 (1H, dd, J = 6.8, 9.5 Hz), 6.23 
(1H, dd, J = 9.5, 12.5 Hz), 7.30-7.34 (2H, m), 7.37-7.43 (9H, m), 
7.45-7.48 (3H, m), 7.50-7.55 (3H, m), 7.70 (1H, m), 7.72-7.91 
(8H, m). 13C NMR: 55.6 (CH), 123.9 (CH), 125.3 (CH), 125.4 
(CH), 125.6 (CH), 126.2 (CH), 127.0 (CH), 127.3 (CH), 128.3 
(CH), 128.4 (d, J = 6.2 Hz, CH), 128.5 (d, J = 12.4 Hz, CH), 
128.7 (CH), 128.8 (CH), 130.5 (C), 131.82 (d, J = 127 Hz, C), 
131.84 (d, J = 2.1 Hz, CH), 131.9 (d, J= 2.1 Hz, CH), 132.0 (d, J 
= 9.3 Hz, CH), 132.4 (d, J = 9.5 Hz, CH), 132.7 (d, J = 127 Hz, 
C), 134.0 (C), 138.4 (d, J= 5.2 Hz, C), 140.0 (C), 140.7 (C), 





). Anal. Calcd for C35H28NOP: C, 82.49; H, 5.54; N, 
2.75. Found: C, 82.23; H, 5.84; N, 2.63. 
6.11.  (–)-N-[Biphenyl-4-yl-(4-methylphenyl)methyl]diphenyl-
phosphinic amide (3d). Chromatography (hexane/Acetone = 
5/1) gave 3d (429 mg, 91%) as colorless solid of mp 187-188 °C. 
[α]22D –16.3 (c 1.09). 69% ee (HPLC, Daicel Chiralpak AD, 
hexane/i-PrOH = 4/1, 1.0 mL/min, 254 nm, major 17.0 min and 
minor 19.2 min). 1H NMR: 2.33 (3H, s), 3.64 (1H, dd, J = 6.7, 
10.1 Hz), 5.47 (1H, dd, J = 10.1, 11.3 Hz), 7.12 (2H, d, J = 7.9 
Hz), 7.19 (2H, d, J = 7.9 Hz), 7.32-7.41 (7H, m), 7.42-7.48 (4H, 
m), 7.49 (2H, d, J = 7.9 Hz), 7.56 (2H, d, J = 7.9 Hz), 7.84-7.88 
(4H, m). 13C NMR: 21.0 (CH3), 58.1 (CH), 127.1 (CH), 127.2 
(CH), 127.3 (CH), 127.5 (CH), 128.0 (CH), 128.4 (d, J = 12.4 Hz, 
CH), 128.8 (CH), 129.3 (CH), 131.9 (CH), 132.3 (d, J = 8.8 Hz, 
CH), 132.36 (d, J = 8.8 Hz, CH), 132.39 (d, J = 129 Hz, C), 132.5 
(d, J = 129 Hz, C), 136.9 (C), 140.0 (C), 140.4 (d, J = 5.2 Hz, C), 
140.8 (C), 142.6 (d, J = 4.1 Hz, C). 31P NMR: 22.2. IR (KBr): 
1184, 725, 694 cm
–1
. EIMS m/z: 473 (M
+
). Anal. Calcd for 
C32H28NOP: C, 81.16; H, 5.96; N, 2.96. Found: C, 80.99; H, 
5.91; N, 2.88.  
6.12. (–)-Diethyl [biphenyl-4-yl(phenyl)methyl]phosphorami-
date (8a). Chromatography (hexane/AcOEt = 4/1) gave 8a (294 
mg, 74%) as colorless solid of mp 124-125 °C. [α]
24
D –13.5 (c 
0.48). 61% ee (HPLC, Daicel Chiralpak OD-H, hexane/i-PrOH = 
15/1, 1.0 mL/min, 254 nm, major 7.9 min and minor 10.2 min). 
1
H NMR: 1.19 (3H, dt, J = 0.9, 7.0 Hz), 1.20 (3H, dt, J = 0.9, 7.0 
Hz), 3.38 (1H, dd, J = 9.8, 9.8 Hz), 3.83-3.91 (2H, m), 3.98-4.06 
(2H, m), 5.47 (1H, dd, J = 9.8, 9.8 Hz), 7.27-7.36 (8H, m), 7.43 
(2H, m), 7.54-7.58 (4H, m). 
13
C NMR: 15.9 (d, J = 3.1 Hz, CH3), 
16.0 (d, J = 3.1 Hz, CH3), 59.0 (CH), 62.4 (d, J = 3.1 Hz, CH2), 
127.1 (CH), 127.2 (CH), 127.3 (CH), 127.4 (CH), 127.6 (CH), 
128.6 (CH), 128.8 (CH), 140.2 (C), 140.7 (C), 142.3 (d, J = 5.1 
Hz, C), 143.2 (d, J = 5.1 Hz, C). 
31
P NMR: 4.55. IR (KBr): 1223, 
763, 702 cm
–1
. EIMS m/z: 395 (M
+
). Anal. Calcd for 
C23H26NO3P: C, 69.86; H, 6.63; N, 3.54. Found: C, 70.02; H, 
6.73; N, 3.53.  
6.13. (–)-Diisopropyl [biphenyl-4-yl(phenyl)methyl]phosphor-
amidate (8b). Chromatography (hexane/AcOEt = 4/1) gave 8b 
(320 mg, 76%) as a white solid of mp 126-127 °C. [α]
25
D –9.8 (c 
1.05). 53% ee (HPLC, Daicel Chiralpak OD-H, hexane/i-PrOH = 
15/1, 1.0 mL/min, 254 nm, major 4.6 min and minor 5.5 min). 
1
H 
NMR: 1.10 (3H, d, J = 6.1 Hz), 1.11 (3H, d, J = 6.1 Hz), 1.29 
(6H, d, J = 6.1 Hz), 3.29 (1H, dd, J = 9.8, 9.8 Hz), 4.52-4.55 (2H, 
m), 5.47 (1H, dd, J = 9.8, 9.8 Hz), 7.26 (1H, m), 7.31-7.36 (7H, 
m), 7.41-7.44 (2H, m), 7.53-7.58 (4H, m). 
13
C NMR: 23.4 (d, J = 
5.1 Hz), 23.5 (d, J = 5.1 Hz, CH3), 23.7 (d, J = 4.1 Hz, CH3), 58.9 
(CH), 71.0 (d, J= 5.1 Hz, CH), 127.1 (CH), 127.2 (CH), 127.3 
(CH), 127.32 (CH), 127.7 (CH), 128.5 (CH), 128.8 (CH), 140.1 
(C), 140.7 (C), 142.6 (d, J = 5.1 Hz, C), 143.4 (d, J = 5.1 Hz, C). 
31
P NMR: 2.64. IR (KBr): 1254, 891, 759 cm
–1
. EIMS m/z: 423 
(M
+
). Anal. Calcd for C25H30NO3P: C, 70.90; H, 7.14; N, 3.31. 
Found: C, 70.70; H, 7.15; N, 3.25.   
6.14. (–)-N-[Biphenyl-4-yl(phenyl)methyl] dicyclohexylphos-
phinic amide (8c). Chromatography (hexane/Acetone = 5/1) gave 
8c (48 mg, 10%) as colorless solid of mp 245-246 °C. [α]23D –15.3 (c 
0.30). 78% ee (HPLC, Daicel Chiralpak AD, hexane/i-PrOH = 15/1, 
1.0 mL/min, 254 nm, major 46.7 min and minor 42.2 min). 1H NMR: 
1.10-1.16 (6H, m), 1.20-1.50 (4H, m), 1.60-1.80 (10H, m), 1.85-1.99 
(2H, m), 2.69 (1H, dd, J = 9.5, 9.5 Hz), 5.71(1H, dd, J = 9.5, 9.5 Hz), 
7.32-7.39 (8H, m), 7.43 (2H, t, J = 7.9 Hz), 7.52-7.61 (4H, m). 13C 
NMR: 25.38 (CH2), 25.40 (CH2), 25.71 (CH2), 25.74 (CH2), 25.77 
(CH2), 25.9 (CH2), 26.4 (d, J = 3.1 Hz, CH2), 26.5 (d, J = 4.1 Hz, 
CH2), 36.3 (d, J = 11.3 Hz, CH), 37.0 (d, J = 12.4 Hz, CH), 127.1 
(CH), 127.2 (CH), 127.3 (CH), 127.6 (CH), 128.1 (CH), 128.5 (CH), 
128.8 (CH), 139.9 (C), 140.8 (C), 143.4 (d, J = 3.1 Hz, C), 144.2 (d, 
J = 3.1 Hz, C). 
31
P NMR: 45.03. IR (KBr): 1164, 702 cm–1. EIMS 
m/z: 471 (M+). HRMS-EI m/z: Calcd for C31H38NOP: 471.2691. 
Found: 471.2684. 
6.15. (–)-N-[Biphenyl-4-yl(phenyl)methyl] bis(3,5-xylyl)phos-
phinic amide (8d). Chromatography (hexane/Et2O = 5/1) gave 
8d (218 mg, 42%) as colorless solid of mp 218-219 °C. [α]
23
D –
17.4 (c 1.00). 67% ee (HPLC, Daicel Chiralpak AD, hexane/i-
PrOH = 15/1, 1.0 mL/min, 254 nm, major 17.5 min and minor 
20.2 min). 
1
H NMR: 2.249 (6H, s), 2.254 (6H, s), 3.60 (1H, dd, J 
= 6.7, 10.1 Hz), 5.49 (1H, dd, J = 10.1, 11.9 Hz), 7.07 (2H, m), 
7.25-7.35 (8H, m), 7.42-7.45 (6H, m), 7.52-7.58 (4H, m). 
13
C 
NMR: 21.1 (CH3), 58.2 (CH), 127.1 (d, J = 10.3 Hz, CH), 127.3 
(d, J = 8.2 Hz, CH), 127.7 (CH), 128.2 (CH), 128.5 (CH), 128.8 
(CH), 129.9 (d, J = 5.1 Hz, CH), 130.0 (d, J = 5.1 Hz, CH), 
133.56 (CH), 133.59 (CH), 138.1 (d, J = 11.3 Hz, C), 140.0 (C), 
140.9 (C), 142.7 (d, J = 3.1 Hz, C), 143.5 (d, J = 5.1 Hz, C). 
31
P 
NMR: 22.17. IR (KBr): 1195, 825, 652 cm
–1
. EIMS m/z: 515 
(M
+
). HRMS-EI m/z: Calcd for C35H34NOP: 515.2378. Found: 
515.2374. 
6.16. (–)-N-[Biphenyl-4-yl(phenyl)methyl] bis(2,4,6-mesityl)-
phosphinic amide (8e). Chromatography (hexane/Acetone = 
5/1) gave 8e (14 mg, 3%) as colorless solid of mp 122-123 °C. 
[α]
23
D –18.1 (c 0.35). 88% ee (HPLC, Daicel Chiralpak AD, 
hexane/i-PrOH = 4/1, 1.0 mL/min, 254 nm, major 11.5 min and 
minor 27.4 min). 
1
H NMR: 2.23 (3H, s), 2.24 (3H, s), 2.27 (6H, 
s), 2.28 (6H, s), 3.68 (1H, dd, J = 5.2, 9.2 Hz), 5.34 (1H, dd, J = 
9.2, 10.4 Hz), 6.74 (2H, s), 6.75 (2H, s), 7.19-7.27 (7H, m), 7.32 
(1H, t, J = 7.6 Hz), 7.42 (2H, t, J = 7.6 Hz), 7.46 (2H, d, J = 8.3 
Hz), 7.54 (2H, d, J = 7.3 Hz). 
13
C NMR: 20.9 (CH3), 22.92 (CH3), 
22.96 (CH3), 22.99 (CH3), 59.9 (CH), 127.0 (CH), 127.1 (CH), 
127.2 (CH), 127.5 (CH), 127.9 (CH), 128.4 (CH), 128.7 (CH), 
129.9 (d, J = 121 Hz, C), 131.0 (d, J = 122 Hz, C), 130.9 (d, J = 
12.4 Hz, CH), 139.8 (C), 140.45 (C), 140.48 (C), 140.51 (C), 
140.9 (C),141.4 (d, J = 10.3 Hz, C), 141.6 (d, J = 10.5 Hz, C), 
143.0 (d, J = 5.1 Hz, C), 143.8 (d, J = 5.1 Hz, C). IR (KBr): 1161, 
721, 648 cm
–1
. EIMS m/z: 544 (M+1). Anal. Calcd for 
C37H38NOP: C, 81.74; H, 7.04; N, 2.58. Found: C, 81.91; H, 
7.18; N, 2.53. 
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